Diagnosis with MCC
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 3, 1998
Issued Date -
N/A
app pub date -
May 19, 1995
filing date -
Mar 13, 1991
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A new human gene termed MCC is disclosed. Antibody based methods and kits are provided for assessing mutations of the MCC gene in human tissues and body samples. Gross rearrangement and point mutations in MCC are observed in human tumor cells. MCC is expressed in most normal tissues. These results suggest that MCC is a tumor suppressor.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully